|
CLCN5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.6251444634463E-12 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
5.177800E-01 |
| Stage1-vs-Stage3 |
2.42339999999563E-05 |
| Stage1-vs-Stage4 |
4.15239999995709E-06 |
| Stage2-vs-Stage3 |
2.622100E-02 |
| Stage2-vs-Stage4 |
1.599670E-02 |
| Stage3-vs-Stage4 |
5.771000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
1.336040E-03 |
| Caucasian-vs-AfricanAmerican |
7.662600E-01 |
| Caucasian-vs-Asian |
3.146800E-01 |
| AfricanAmerican-vs-Asian |
2.511000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62503344114384E-12 |
| Male-vs-Female |
1.58590000021164E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
9.5726000459706E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.268000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.010620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.876200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.614000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.954600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.596600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.37780000000343E-05 |
| Normal-vs-Grade 2 |
1.62447832963153E-12 |
| Normal-vs-Grade 3 |
1.62436730732907E-12 |
| Normal-vs-Grade 4 |
<1E-12 |
| Grade 1-vs-Grade 2 |
2.902800E-01 |
| Grade 1-vs-Grade 3 |
9.163800E-02 |
| Grade 1-vs-Grade 4 |
4.20410000034899E-07 |
| Grade 2-vs-Grade 3 |
1.434020E-01 |
| Grade 2-vs-Grade 4 |
5.88662452116751E-12 |
| Grade 3-vs-Grade 4 |
9.89979997978452E-09 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.44249065417534E-14 |
| Normal-vs-ccB subtype |
<1E-12 |
| ccA subtype-vs-ccB subtype |
1.62436730732907E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.4623968702665E-11 |
| N0-vs-N1 |
5.190000E-02 |
|
|
